This Thursday, August 26th, our Distance Learning Division has lined up a panel of experts to delve into the complex issues surrounding gene-based patents in the wake of the Myriad decision. The Future of Patenting in Biomedicine: An In-Depth Look at the Effect of the Myriad Case on Gene Patenting and Genetic Diagnostics will address host of issues including:
- How to analyze diagnostic claims
- The significance of the “detecting” step with regard to novelty
- The relevance of any “mental steps” involved in patent claims
- What to expect from the Federal Circuit
- The significance of genetic methods as a subset of medical diagnostic claims
- The relationship between information per se and methods of obtaining information.
For complete information and to enroll, please CLICK HERE >>>
Plus, don’t miss these upcoming distance learning programs:
Posted August 24th, 2010 under Audioconferences, Intellectual Property Marketing
|
|
|
|
Write a comment